SlideShare ist ein Scribd-Unternehmen logo
1 von 59
Introduction
The antimicrobials are not a human
invention.
 They were present/produced by fungi,
soil actinomycetes, and other
microorganisms for the last few
thousand of years.
 To counteract the effects of these,
genes encoding for resistance have also
been present in nature for similar time
period.

Introduction


Introduction of these genes in
human/animal commensal flora or
pathogenic organisms together with the
introduction of antimicrobials for human
use has led to the present day epidemic
of antimicrobial resistance.
Antimicrobial use and Resistance
Antimicrobial use and
Resistance










A few million years ago, one species of finch
migrated to the rocky Galapagos from the mainland
of Central or South America.
From this one migrant species would come many -at least 13 species of finch evolving from the single
ancestor.
This process in which one species gives rise to
multiple species that exploit different niches is called
adaptive radiation.
On various islands, finch species have become
adapted for different diets: seeds, insects, flowers,
the blood of seabirds, and leaves.
The ecological niches exert the selection pressures
that push the populations in various directions.
Antimicrobial use and
Resistance
Darwinian theories of evolution and
survival of the fittest suggest that the
selection and maintenance of MDR
bacteria would not happen without
antibiotic exposure and the heavier the
exposure, the greater the resistance
problem.
 Emergence of VRE due to vancomycin
use (?); carbapenem resistance in
Acinetobacter and other GNB.

Antimicrobial use and
Resistance
Emergence of VRE due to usage of broad
spectrum cephalosporins and clindamycin.
 Fluoroquinolone with MRSA (quinolones
are known to modulate phage induction
and and horizontal gene transfer)
 High-level fluoroquinolone resistance
(mainly caused by gyrA mutations) has
also been shown to be associated with
CTX-M enzymes (co-carriage on
conjugative plasmids).

Antimicrobial use and
Resistance
As bacteria are thought to have evolved
3500 million years ago, 60-70 years is
but „a second in a day‟ in evolutionary
time.
 Despite this, we have seen the
development, even since their early use,
of antibiotic resistance in many bacterial
species.

Antimicrobial use and
Resistance


Antibiotic resistance genes were
present at very low levels prior to the
introduction of antibiotics and it is largely
the selective pressure of antibiotic use
and the resulting exposure of bacteria,
not only in humans but also in animals
and the environment, which has caused
the rise.
Causal associations between antimicrobial use and
the emergence of antimicrobial resistance.

Changes in antimicrobial use are
paralleled by changes in the prevalence
of resistance.
 Antimicrobial resistance is more
prevalent in health care–associated
bacterial infections, compared with
those from community-acquired
infections.

Causal associations between antimicrobial use and
the emergence of antimicrobial resistance

Patients with health care–associated
infections caused by resistant strains are
more likely than control patients to have
received prior antimicrobials.
 Areas within hospitals that have the highest
rates of antimicrobial resistance also have
the highest rates of antimicrobial use.
 Increasing duration of patient exposure to
antimicrobials increases the likelihood of
colonization with resistant organisms.

Antibiotic Use

Antibiotic Use

Causes Resistance

Maintains Resistance

Don’t forget antibiotic
use to modulate
resistance and control
outbreaks eg. patient
decontamination
regimens

By Patient-staff-patient
Spreads Resistance
Patient-patient
?Patient-environment / equipment – patient

Cross Infection
What is antimicrobial stewardship?


Stewardship – „careful and
responsible management
of something entrusted to
one‟s care‟.



Antimicrobial stewardship
refers to the „careful and
responsible management
of antimicrobials entrusted
to the care of ……



Usually medical
microbiologists, infectious
diseases physicians,
antimicrobial pharmacists,
infection control nurses
etc.
Antimicrobial Stewardship


An antimicrobial stewardship program is
an ongoing effort by a health care
institution to optimize antimicrobial use
among hospitalized patients in order to
improve patient outcomes, ensure costeffective therapy, and reduce adverse
sequelae of antimicrobial use (including
antimicrobial resistance).(MacDougall and Polk
2005, Clin Microbiol Rev,18).
Antimicrobial Stewardship


Antimicrobial stewardship entails diverse
interventions aimed at reducing
inappropriate antimicrobial use while
optimizing antimicrobial drug selection,
dosing, route and duration of therapy in
order to maximize clinical cure or
prevention of infection and to limit
unintended consequences, such as the
emergence of resistance, adverse drug
events and the selection of pathogenic
organisms. (Dellit TH et al 2007 Clin Infect Dis,44)
Antimicrobial Stewardship
The optimal selection, dosage, and
duration of antimicrobial treatment that
results in the best clinical outcome for the
treatment or prevention of infection, with
minimal toxicity to the patients and minimal
impact on subsequent resistance.
 4 D‟s of optimal antimicrobial therapy are:
right Drug, right Dose, De-escalation to
pathogen directed therapy, and right
Duration of therapy.

ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

Infectious Diseases Physicians:
 Design, implementation, and function
of the program.
 Supervision by an infectious diseases
physician is necessary to ensure that
therapeutic guidelines, antimicrobial
restriction policies, or other measures
are based on the best evidence and
practice and will not put patients at risk.

1.
ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

2. Clinical and Hospital Pharmacists
 Pharmacists often act as the effector
arms for antimicrobial stewardship
programs
 They are well positioned for this effort
because of their role in processing
medication orders and their familiarity
with the hospital formulary.
ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

However, the broad responsibilities of
these pharmacists generally do not
allow adequate time for a
comprehensive review of antimicrobial
therapy.
 In addition, these pharmacists may not
have adequate training in infectious
diseases to feel comfortable providing
recommendations for complex cases.

ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

3. Clinical Microbiologists
 The clinical microbiology laboratory is a
key component in the function of
antimicrobial stewardship programs.
 Summary data on antimicrobial resistance
rates allow the antimicrobial stewardship
team to determine the current burden of
antimicrobial resistance in the hospital,
facilitating decisions as to which
antimicrobials to target for restriction or
review.
ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

Preparation of antibiograms specific to
certain patient care areas, especially
intensive care units, may allow
identification of local problems and
focussed antimicrobial stewardship and
infection control efforts
 Dissemination of antibiograms to
clinicians may allow better selection of
empirical therapy based on local
susceptibility patterns.

ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

The microbiology laboratory can also
encourage focused antimicrobial selection
by cascade reporting of susceptibility
results: depending on the organism‟s
susceptibility, only certain (usually
narrower-spectrum) antimicrobials are
reported.
 Hidden susceptibility results should be
made available upon request in cases
where toxicity, allergy, co-infections, or
other considerations make first-line therapy
suboptimal.

ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

4. Infection Control Staff and Hospital
Epidemiologists
 Infection control staff gather highly detailed
data on nosocomial infections which may
assist in the antimicrobial stewardship
team‟s evaluation of the outcomes of their
strategies.
 In turn, antimicrobial stewardship
programs may be able to assist in efforts to
control outbreaks by focused monitoring
and/or restriction of antimicrobials in the
targeted units
ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS


Any antimicrobial stewardship program
should either be fully integrated with or
work closely with a hospital‟s infection
control program; such collaboration has
the opportunity to synergistically reduce
antimicrobial resistance and improve
patient outcomes.
ROLES OF INDIVIDUALS IN ANTIMICROBIAL
STEWARDSHIP PROGRAMS

5. Hospital Administrators
 No

antimicrobial stewardship program is
likely to be successful without at least
passive endorsement by hospital
leadership.
 Program funding, institutional policy, and
physician autonomy are core issues in the
development of antimicrobial stewardship
programs that must be addressed by
hospital administration.
ROLES OF INDIVIDUALS IN
ANTIMICROBIAL
STEWARDSHIP PROGRAMS
 Without adequate support from hospital
leadership, program funding will be
inadequate or inconsistent since the
programs do not generate revenue.
 If hospital leadership is not publicly
committed to the program, recalcitrant
prescribers may thwart attempts to
improve antimicrobial use without fear of
sanction.
Methodological Issues
Outcome Measurements
 The change in antimicrobial usage is the
most common outcome measured in
studies of stewardship programs.
 Common outcome variables include
quantity of total antimicrobial use, quantity
of targeted antimicrobial use, duration of
therapy, percentage of oral versus
intravenous drug administration, and
antimicrobial drug expenditures.
1.
Methodological Issues-1.
Outcome measurements
Common clinical outcomes include allcause mortality, infection-related
mortality, duration of hospitalization, and
rates of readmission.
 Microbiologic outcomes include the
percentage of organisms resistant to a
certain antimicrobial, percentage of
multidrug-resistant organisms, or
number of infections due to specific
organisms.

Methodological Issues
2. Study Design
 Use of flawed methodologies may
overestimate or underestimate the effect of
interventions on outcomes.
 In a review of 306 studies of interventions
to improve antimicrobial prescribing in
hospitals, 70% did not meet the minimum
criteria of the Cochrane Collaboration‟s
Effective Practice and Organization of Care
Group. (Ramsey et al 2003, J Antimicrob Chemother; 52).
Methodological Issues-2. Study
Design






The most commonly excluded studies were those
using uncontrolled before-and-after designs (46%) or
inadequate interrupted time series analysis (24%).
Analysis need to be done using interrupted time
series with segmented regression , a method of
analysis applied to before-and-after quasiexperimental study designs.
This methodology requires measurements at multiple
time points both before and after the intervention,
allowing evaluation of both the immediate change
due to the intervention (change in level) and the
sustained changes (change in slope).
Segmented regression analysis of interrupted time series data.
Methodological Issues
3. Effect of Multiple Interventions
 Analysis of the efficacy of interventions
to improve antimicrobial use is
complicated by the simultaneous
employment of multiple different
strategies by antimicrobial stewardship
programs.
 It becomes difficult to compare the
effect of different strategies and
conclude which is most effective.
Methodological Issues
4. Publication Bias
 There is a perception that positive results are more
noteworthy and manuscripts are more likely to be
submitted and accepted for publication if the report
demonstrates positive results
 Thus, it is unclear whether antimicrobial stewardship
programs are generally effective in controlling
antimicrobial use (and sometimes in improving
resistance and clinical outcomes), or whether the
published literature only reflects the experience of
successful programs.
 The careful study and publication of the results of
implementations of antimicrobial stewardship
strategies, successful or unsuccessful, should be
encouraged.
Antibiotic Stewardship
Programmes/Strategies



1.
2.
3.
4.
5.

Antimicrobial stewardship programs may be
generally classified according to the strategy
by which they seek to affect antimicrobial use.
However many programs use a combination
of such strategies.
Education and Guideline Implementation
Strategies
Formulary and Restriction Strategies
Review and Feedback Strategies
Computer-Assisted Strategies
Antibiotic Cycling Strategies.
1. Education and Guideline
Implementation Strategies








A key foundation in encouraging appropriate
antimicrobial use in hospitals is defining what an
institution considers appropriate antimicrobial use.
Because of limited time to teach antimicrobial
pharmacology and infectious diseases in the medical
school curriculum, physicians often acquire their
antimicrobial prescribing habits from
the practice of their colleagues,
the recommendations of antibiotic handbooks, and
from information provided by representatives of the
pharmaceutical industry
1. Education and Guideline
Implementation Strategies
Information from these sources may
vary widely and conflict with what is
considered best practice at an
institution.
 Although the vast majority of physicians
recognize antimicrobial resistance as an
important problem, most underestimate
the true degree of antimicrobial
resistance in their own institutions

1. Education and Guideline
Implementation Strategies
Physicians are primarily concerned with
the effects of antimicrobials in the
individual patients whose care they have
been charged with.
 In a hypothetical case scenario, the risk
of contributing to antimicrobial
resistance was rated lowest among
seven factors influencing a physician‟s
choice of antimicrobial agent.

1. Education and Guideline
Implementation Strategies
To counter these perceived conflicts in
knowledge and practice, institutions may
attempt to provide guidelines for
antimicrobial use and educate clinicians
regarding preferred antimicrobial
therapy.
 This strategy attempts to influence
providers‟ prescribing during their
evaluation of the patient and selection of
antimicrobial therapy

1. Education and Guideline
Implementation Strategies
Academic detailing refers to one-on-one
educational sessions between an
academic clinician educator (usually a
physician or pharmacist) and the clinician
targeted for education .
 Also referred to as reverse detailing or
counterdetailing, this method co-opts the
strategy of individualized attention used by
pharmaceutical industry representatives
(detailers).

1. Education and Guideline
Implementation Strategies
Prescriber feedback consists of providing
data to clinicians regarding their
prescribing habits, with comparisons to
expected norms (e.g.guidelines) or to other
prescribers in the same practice area.
 In the hospital setting, passive
interventions involve measures such as
providing posters, handouts, or printed
guidebooks, or minimally interactive
educational sessions such as Grand
Rounds.

1. Education and Guideline
Implementation Strategies
Reviews of studies of provider behaviour
change suggest that active,
personalized interventions such as
academic detailing are more effective
than passive dissemination of
information at eliciting desired changes.
 Education- and guideline-based
strategies should be considered
primarily as a starting point for
antimicrobial stewardship programs.

2. Formulary and Restriction
Strategies
Because of resistance to compliance
with guidelines for antimicrobial usage,
external control over clinicians‟
prescribing of these drugs may be
implemented.
 This commonly takes the form of
establishment of an antimicrobial
formulary, such that only selected
antimicrobial agents are freely
dispensed by the pharmacy.

2. Formulary and Restriction
Strategies




Other agents may only be available if certain criteria
for use are met (criterion-monitored strategies), if
approval for use is obtained from a specialist in
infectious diseases (prior-authorization strategies), or
may not be available at all (closed-formulary
strategies).
The goal of restriction-based policies may be a
reduction in drug costs to the hospital (through
restriction of more-expensive agents), a reduction in
the growth of antimicrobial resistance (through
restriction of agents considered to be more likely to
contribute to resistance), or both.
2. Formulary and Restriction
Strategies
Restriction programs may also be based
on the potential of antimicrobials to
select for certain resistant organisms.
 “Squeezing the balloon” phenomenon;
changing from the use of one agent to
another may reduce resistance to the
first drug, but increase resistance to the
second drug.

2. Formulary and Restriction
Strategies




In response to an outbreak of an extended-spectrum
beta-lactamase-producing Klebsiella sp., a hospital
instituted strict restrictions on all cephalosporin use .
Subsequently, the incidence of resistant Klebsiella
infection decreased significantly. However, due to an
increase in use of imipenem/cilastatin, the incidence
of imipenem-resistant Pseudomonas aeruginosa
increased.
Heavy use of piperacillin-tazobactam was
associated with high rates of piperacillin-resistant
Pseudomonas infections in a medical-surgical
intensive care unit . Substitution of Pip-Taz with
imipenem led to a decrease in resistance piperacillin
resistance in Pseudomonas infections, but an
increase in imipenem resistance.
3. Review and Feedback
Strategies
Restriction strategies may be effective at
channelling use of antimicrobials towards
preferable agents, but there are limitations
to the approach.
 There may be inadequate personnel or
institutional commitment for a restrictive
approach.
 Restriction strategies do not consider the
appropriateness of use of non-restricted
antimicrobials, which make up the vast
majority of antimicrobials used in the
hospital.

3. Review and Feedback
Strategies




To optimize the use of non-restricted
antimicrobials, or to manage the use of
targeted antimicrobials in institutions where
restriction strategies are not in place,
programs built around antimicrobial review and
feedback may be instituted.
Such a program involves the retrospective
(hours to days) review of antimicrobial orders

If an order appears to be inappropriate, a
member of the antimicrobial management
team contacts the prescriber in an effort to
optimize therapy.
3. Review and Feedback
Strategies






Review and feedback strategies may be especially
important in streamlining antimicrobial use.
This realization has led to the advocacy of early,
broad-spectrum empirical antimicrobial therapy for a
number of hospital infections.
For example, recent American Thoracic
Society/Infectious Diseases Society of America
guidelines for hospital-acquired pneumonia
recommend three-drug combination therapy (an
antipseudomonal beta-lactam, an aminoglycoside or
fluoroquinolone, and vancomycin or linezolid) for
empirical therapy in patients with late-onset
pneumonia.
3. Review and Feedback
Strategies
This approach reduces the risk of a
patient‟s receiving inadequate therapy;
 However, administration of multiple broadspectrum agents may increase the risk of
development of resistance in the patient‟s
(and the hospital‟s) bacterial flora.
 Thus, it is crucial for clinicians to change to
the narrowest spectrum appropriate agent
to treat the infecting pathogen once it is
isolated and discontinue antimicrobials if
infection is unlikely.

3. Review and Feedback
Strategies


Although adherence to these two
principles should be a fundamental tenet
of medical practice, in reality a formal
process (such as a guideline or critical
pathway) or the contribution of the
antimicrobial stewardship team
reviewing such orders may be required.
4. Computer-Assisted
Strategies
The increasing computerization of the
hospital environment offers new
opportunities for programmes to optimize
antimicrobial use.
 These opportunities have primarily been
associated with implementation of
computerized physician order-entry
systems in hospitals.
 The order-entry encounter can be designed
to facilitate each of the antimicrobial
stewardship strategies .

4. Computer-Assisted
Strategies






Educational strategies may be as simple as a link to
the institution‟s guidelines for therapy, or as
sophisticated as computerized expert systems that
integrate patient-specific laboratory and microbiology
data in devising a suggested therapeutic regimen.
If a prescriber enters an order for a restricted agent,
a list of formulary alternatives can be suggested,
along with the pager number needed to obtain
authorization.
When an agent targeted for review is ordered, the
data can be forwarded in real time or entered into a
queue for later review by antimicrobial stewardship
personnel.
4. Computer-Assisted
Strategies






The most advanced programs integrate
patient-specific data extracted from hospital
information systems to provide tailored
recommendations for therapy using rulesbased criteria (expert systems).
The choice of antimicrobial is guided by the
results of the patient‟s cultures (for definitive
therapy) or by hospital-specific resistance
patterns (for empirical therapy).
Many softwares are commercially available
which can be integrated in hospital information
system.
5. Antibiotic Cycling Strategies
In the 1980s, studies examining formulary
substitution of aminoglycosides (amikacin
for gentamicin and tobramycin) suggested
a strategy of rotating antimicrobials might
be effective in slowing the emergence of
resistance to any one agent.
 These studies have led to the
development of strategies utilizing the
scheduled rotation of antimicrobials in
order to minimize the emergence of
bacterial resistance.

5. Antibiotic Cycling Strategies






These programs typically target Gram-negative
resistance (the cycled antimicrobials are those
primarily active against Gram-negative organisms)
and are generally limited to the intensive care unit
setting.
Theoretically, during the periods when an
antimicrobial is out of rotation and its use is minimal,
resistance to that drug will decline.
The idea is to reduce selective pressure to any one
antimicrobial class by providing heterogeneity in drug
use –in the case of cycling, temporal heterogeneity
(by time period) rather than spatial (by patient)
heterogeneity.
5. Antibiotic Cycling Strategies


However, compliance with the cycling
protocol may be low, for a number of
reasons: physicians may ignore the
protocol and prescribe off-cycle
antimicrobials to their patients, allergies
or toxicity may preclude administration
of the on-cycle drug, and the final
regimen may be tailored to culture
results.
Conclusions
Although resistance is a worldwide
concern, it is first and foremost a local
problem: selection for and amplification of
resistant members of a species are
occurring in individual hospitals (and
communities), which can then spread
worldwide.
 Commitment to implementation of
antimicrobial stewardship programs must
come from the highest levels of hospital
administration.

Conclusions
Once a commitment to establishing an
antimicrobial stewardship program is
made, program personnel/committee
need to be put into place.
 The committee then needs to decide
what strategies their program will use to
improve antimicrobial use.

T

Weitere ähnliche Inhalte

Was ist angesagt?

OVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPOVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPTanveerRehman4
 
Antibiotic stewardship by dr praman
Antibiotic stewardship by dr pramanAntibiotic stewardship by dr praman
Antibiotic stewardship by dr pramanDr Praman Kushwah
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Tahseen Siddiqui
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardshipdrakmane
 
Antibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptxAntibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptxsunnysingh906052
 
Antibiotic Stewardship ppt.pptx
Antibiotic Stewardship ppt.pptxAntibiotic Stewardship ppt.pptx
Antibiotic Stewardship ppt.pptxAfkar432
 
Antibiotic stewardship programme hiht final 3nov2012
Antibiotic stewardship programme hiht final 3nov2012Antibiotic stewardship programme hiht final 3nov2012
Antibiotic stewardship programme hiht final 3nov2012Vikas Kesarwani
 
antibiotic policy
antibiotic policy antibiotic policy
antibiotic policy ChristyMebin
 
Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016SCGH ED CME
 
Antibiotic resistance dr sachin
Antibiotic resistance dr sachinAntibiotic resistance dr sachin
Antibiotic resistance dr sachinSachin Verma
 
Antbiotic resistance
Antbiotic resistanceAntbiotic resistance
Antbiotic resistancepodila shree
 
Antimicrobial resistance (amr)
Antimicrobial resistance (amr)Antimicrobial resistance (amr)
Antimicrobial resistance (amr)SmritiAcharya4
 

Was ist angesagt? (20)

OVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPOVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIP
 
Antibiotic stewardship by dr praman
Antibiotic stewardship by dr pramanAntibiotic stewardship by dr praman
Antibiotic stewardship by dr praman
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD
 
Antibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptxAntibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptx
 
Antibiotic Stewardship ppt.pptx
Antibiotic Stewardship ppt.pptxAntibiotic Stewardship ppt.pptx
Antibiotic Stewardship ppt.pptx
 
Antibiotic stewardship programme hiht final 3nov2012
Antibiotic stewardship programme hiht final 3nov2012Antibiotic stewardship programme hiht final 3nov2012
Antibiotic stewardship programme hiht final 3nov2012
 
antibiotic policy
antibiotic policy antibiotic policy
antibiotic policy
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Antimicrobial Resistance
Antimicrobial ResistanceAntimicrobial Resistance
Antimicrobial Resistance
 
Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic resistance dr sachin
Antibiotic resistance dr sachinAntibiotic resistance dr sachin
Antibiotic resistance dr sachin
 
INTERPRETATION OF ANTIBIOGRAMS Trends of Change
INTERPRETATION OF ANTIBIOGRAMSTrends of Change  INTERPRETATION OF ANTIBIOGRAMSTrends of Change
INTERPRETATION OF ANTIBIOGRAMS Trends of Change
 
Antbiotic resistance
Antbiotic resistanceAntbiotic resistance
Antbiotic resistance
 
Antimicrobial resistance (amr)
Antimicrobial resistance (amr)Antimicrobial resistance (amr)
Antimicrobial resistance (amr)
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 

Andere mochten auch

Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipThe CRUDEM Foundation
 
Bacterial persistence
Bacterial persistenceBacterial persistence
Bacterial persistenceYung-Tsai Chu
 
Advisor Live: Antimicrobial Stewardship - Why Now and How?
Advisor Live: Antimicrobial Stewardship - Why Now and How?Advisor Live: Antimicrobial Stewardship - Why Now and How?
Advisor Live: Antimicrobial Stewardship - Why Now and How?Premier Inc.
 
Antimicrobial Stewardship (PROA) Journal Watch
Antimicrobial Stewardship (PROA) Journal WatchAntimicrobial Stewardship (PROA) Journal Watch
Antimicrobial Stewardship (PROA) Journal WatchPROANTIBIOTICOS
 
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
Antimicrobial Stewardship  ,Heba Abdallatif,BCPSAntimicrobial Stewardship  ,Heba Abdallatif,BCPS
Antimicrobial Stewardship ,Heba Abdallatif,BCPSHeba Abd Allatif
 
Antibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJUAntibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJUDr Madhuri Rudraraju
 
Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1anusil
 
Antibiotic resistance
Antibiotic resistance Antibiotic resistance
Antibiotic resistance Naser Tadvi
 

Andere mochten auch (9)

Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic Stewardship
 
Bacterial persistence
Bacterial persistenceBacterial persistence
Bacterial persistence
 
Advisor Live: Antimicrobial Stewardship - Why Now and How?
Advisor Live: Antimicrobial Stewardship - Why Now and How?Advisor Live: Antimicrobial Stewardship - Why Now and How?
Advisor Live: Antimicrobial Stewardship - Why Now and How?
 
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
 
Antimicrobial Stewardship (PROA) Journal Watch
Antimicrobial Stewardship (PROA) Journal WatchAntimicrobial Stewardship (PROA) Journal Watch
Antimicrobial Stewardship (PROA) Journal Watch
 
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
Antimicrobial Stewardship  ,Heba Abdallatif,BCPSAntimicrobial Stewardship  ,Heba Abdallatif,BCPS
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
 
Antibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJUAntibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJU
 
Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1Antibiotic resistance in bacteria 1
Antibiotic resistance in bacteria 1
 
Antibiotic resistance
Antibiotic resistance Antibiotic resistance
Antibiotic resistance
 

Ähnlich wie Antimicrobial stewardship

An tibiotic policy in medical care seminar
An tibiotic policy in medical care seminarAn tibiotic policy in medical care seminar
An tibiotic policy in medical care seminardeepak deshkar
 
Management of antibiotic resistance upload
Management of antibiotic resistance uploadManagement of antibiotic resistance upload
Management of antibiotic resistance uploadAnimesh Gupta
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & ArnabArghya Chowdhury
 
Antimicrobial stewardship clostridium difficile
Antimicrobial stewardship clostridium difficileAntimicrobial stewardship clostridium difficile
Antimicrobial stewardship clostridium difficileDavid A. Godinez
 
Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)Apollo Hospitals
 
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...Theresa Lowry-Lehnen
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxDr. Kiran Dhamak
 
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptx
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptxANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptx
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptxAmeetRathod3
 
Antimicrobial resistance new
Antimicrobial resistance newAntimicrobial resistance new
Antimicrobial resistance newpgims,rohtak
 
Indiscriminate use of antibiotics amongst Nigerians.docx
Indiscriminate use of antibiotics amongst Nigerians.docxIndiscriminate use of antibiotics amongst Nigerians.docx
Indiscriminate use of antibiotics amongst Nigerians.docxEdwinOkon1
 
Antibiotic Resistance .pptx
Antibiotic Resistance .pptxAntibiotic Resistance .pptx
Antibiotic Resistance .pptxIabcrJournal
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceSantosh Reddy
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceSantosh Reddy
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROsYaser Ammar
 

Ähnlich wie Antimicrobial stewardship (20)

An tibiotic policy in medical care seminar
An tibiotic policy in medical care seminarAn tibiotic policy in medical care seminar
An tibiotic policy in medical care seminar
 
Management of antibiotic resistance upload
Management of antibiotic resistance uploadManagement of antibiotic resistance upload
Management of antibiotic resistance upload
 
Project amr by Arghya & Arnab
Project amr by Arghya & ArnabProject amr by Arghya & Arnab
Project amr by Arghya & Arnab
 
Antimicrobial stewardship clostridium difficile
Antimicrobial stewardship clostridium difficileAntimicrobial stewardship clostridium difficile
Antimicrobial stewardship clostridium difficile
 
Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)Combating Drug Resistance in The Intensive Care Unit (ICU)
Combating Drug Resistance in The Intensive Care Unit (ICU)
 
ARE INTENSIVE CARE UNITS (ICU’s) A THREAT TO LIFE?
ARE INTENSIVE CARE UNITS (ICU’s) A THREAT TO LIFE? ARE INTENSIVE CARE UNITS (ICU’s) A THREAT TO LIFE?
ARE INTENSIVE CARE UNITS (ICU’s) A THREAT TO LIFE?
 
Wvd presentation pdf
Wvd presentation pdfWvd presentation pdf
Wvd presentation pdf
 
Antibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in IndiaAntibiotic Resistance Scenario in India
Antibiotic Resistance Scenario in India
 
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...
Antimicrobial Resistance: A Major Cause for Concern and a Collective Responsi...
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
 
Acs0815 Antibiotics
Acs0815 AntibioticsAcs0815 Antibiotics
Acs0815 Antibiotics
 
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptx
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptxANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptx
ANTIBOITICS TO RESISTANCE. MENACE TO CONTROL.pptx
 
Antimicrobial resistance new
Antimicrobial resistance newAntimicrobial resistance new
Antimicrobial resistance new
 
Indiscriminate use of antibiotics amongst Nigerians.docx
Indiscriminate use of antibiotics amongst Nigerians.docxIndiscriminate use of antibiotics amongst Nigerians.docx
Indiscriminate use of antibiotics amongst Nigerians.docx
 
Antibiotic Resistance .pptx
Antibiotic Resistance .pptxAntibiotic Resistance .pptx
Antibiotic Resistance .pptx
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
 
General information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistanceGeneral information on antibiotics and antibiotic resistance
General information on antibiotics and antibiotic resistance
 
AMSP PPT.pptx
AMSP PPT.pptxAMSP PPT.pptx
AMSP PPT.pptx
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs
 

Mehr von Abhijit Chaudhury

Immunology of lymphatic filariasis
Immunology of lymphatic filariasisImmunology of lymphatic filariasis
Immunology of lymphatic filariasisAbhijit Chaudhury
 
Immunological tests in parasitology
Immunological tests in parasitologyImmunological tests in parasitology
Immunological tests in parasitologyAbhijit Chaudhury
 
Immunology of helminth infections
Immunology of helminth infectionsImmunology of helminth infections
Immunology of helminth infectionsAbhijit Chaudhury
 
Classification of Enterobacteriaceae family
Classification of Enterobacteriaceae familyClassification of Enterobacteriaceae family
Classification of Enterobacteriaceae familyAbhijit Chaudhury
 
Antiviral agents and sensitivity tests
Antiviral agents and sensitivity testsAntiviral agents and sensitivity tests
Antiviral agents and sensitivity testsAbhijit Chaudhury
 
Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesAbhijit Chaudhury
 
Ventilator Associated Pneumonia control
Ventilator Associated Pneumonia controlVentilator Associated Pneumonia control
Ventilator Associated Pneumonia controlAbhijit Chaudhury
 
Lab support in hiv treatment and management
Lab support in hiv treatment and managementLab support in hiv treatment and management
Lab support in hiv treatment and managementAbhijit Chaudhury
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisAbhijit Chaudhury
 

Mehr von Abhijit Chaudhury (13)

Immunology of lymphatic filariasis
Immunology of lymphatic filariasisImmunology of lymphatic filariasis
Immunology of lymphatic filariasis
 
Immunological tests in parasitology
Immunological tests in parasitologyImmunological tests in parasitology
Immunological tests in parasitology
 
Immunology of helminth infections
Immunology of helminth infectionsImmunology of helminth infections
Immunology of helminth infections
 
Classification of Enterobacteriaceae family
Classification of Enterobacteriaceae familyClassification of Enterobacteriaceae family
Classification of Enterobacteriaceae family
 
Antiviral agents and sensitivity tests
Antiviral agents and sensitivity testsAntiviral agents and sensitivity tests
Antiviral agents and sensitivity tests
 
Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and Vaccines
 
Ventilator Associated Pneumonia control
Ventilator Associated Pneumonia controlVentilator Associated Pneumonia control
Ventilator Associated Pneumonia control
 
Entomophthroramycosis
EntomophthroramycosisEntomophthroramycosis
Entomophthroramycosis
 
Lab support in hiv treatment and management
Lab support in hiv treatment and managementLab support in hiv treatment and management
Lab support in hiv treatment and management
 
Blood stream infections
Blood stream infectionsBlood stream infections
Blood stream infections
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
 
Human parasite vaccines
Human parasite vaccinesHuman parasite vaccines
Human parasite vaccines
 
Neglected tropical diseases
Neglected tropical diseasesNeglected tropical diseases
Neglected tropical diseases
 

Kürzlich hochgeladen

HONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsHONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsMichael W. Hawkins
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdfRenandantas16
 
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLSeo
 
Call Girls in Gomti Nagar - 7388211116 - With room Service
Call Girls in Gomti Nagar - 7388211116  - With room ServiceCall Girls in Gomti Nagar - 7388211116  - With room Service
Call Girls in Gomti Nagar - 7388211116 - With room Servicediscovermytutordmt
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxAndy Lambert
 
Boost the utilization of your HCL environment by reevaluating use cases and f...
Boost the utilization of your HCL environment by reevaluating use cases and f...Boost the utilization of your HCL environment by reevaluating use cases and f...
Boost the utilization of your HCL environment by reevaluating use cases and f...Roland Driesen
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMRavindra Nath Shukla
 
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature Set
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature SetCreating Low-Code Loan Applications using the Trisotech Mortgage Feature Set
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature SetDenis Gagné
 
Grateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfGrateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfPaul Menig
 
VIP Call Girls In Saharaganj ( Lucknow ) 🔝 8923113531 🔝 Cash Payment (COD) 👒
VIP Call Girls In Saharaganj ( Lucknow  ) 🔝 8923113531 🔝  Cash Payment (COD) 👒VIP Call Girls In Saharaganj ( Lucknow  ) 🔝 8923113531 🔝  Cash Payment (COD) 👒
VIP Call Girls In Saharaganj ( Lucknow ) 🔝 8923113531 🔝 Cash Payment (COD) 👒anilsa9823
 
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxB.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxpriyanshujha201
 
7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...Paul Menig
 
A305_A2_file_Batkhuu progress report.pdf
A305_A2_file_Batkhuu progress report.pdfA305_A2_file_Batkhuu progress report.pdf
A305_A2_file_Batkhuu progress report.pdftbatkhuu1
 
Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Roland Driesen
 
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...Aggregage
 
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...Dipal Arora
 
It will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayIt will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayNZSG
 
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...Any kyc Account
 

Kürzlich hochgeladen (20)

HONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsHONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael Hawkins
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
 
Call Girls in Gomti Nagar - 7388211116 - With room Service
Call Girls in Gomti Nagar - 7388211116  - With room ServiceCall Girls in Gomti Nagar - 7388211116  - With room Service
Call Girls in Gomti Nagar - 7388211116 - With room Service
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptx
 
Boost the utilization of your HCL environment by reevaluating use cases and f...
Boost the utilization of your HCL environment by reevaluating use cases and f...Boost the utilization of your HCL environment by reevaluating use cases and f...
Boost the utilization of your HCL environment by reevaluating use cases and f...
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSM
 
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature Set
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature SetCreating Low-Code Loan Applications using the Trisotech Mortgage Feature Set
Creating Low-Code Loan Applications using the Trisotech Mortgage Feature Set
 
Grateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfGrateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdf
 
VIP Call Girls In Saharaganj ( Lucknow ) 🔝 8923113531 🔝 Cash Payment (COD) 👒
VIP Call Girls In Saharaganj ( Lucknow  ) 🔝 8923113531 🔝  Cash Payment (COD) 👒VIP Call Girls In Saharaganj ( Lucknow  ) 🔝 8923113531 🔝  Cash Payment (COD) 👒
VIP Call Girls In Saharaganj ( Lucknow ) 🔝 8923113531 🔝 Cash Payment (COD) 👒
 
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxB.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
 
7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...7.pdf This presentation captures many uses and the significance of the number...
7.pdf This presentation captures many uses and the significance of the number...
 
A305_A2_file_Batkhuu progress report.pdf
A305_A2_file_Batkhuu progress report.pdfA305_A2_file_Batkhuu progress report.pdf
A305_A2_file_Batkhuu progress report.pdf
 
Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...
 
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
 
VVVIP Call Girls In Greater Kailash ➡️ Delhi ➡️ 9999965857 🚀 No Advance 24HRS...
VVVIP Call Girls In Greater Kailash ➡️ Delhi ➡️ 9999965857 🚀 No Advance 24HRS...VVVIP Call Girls In Greater Kailash ➡️ Delhi ➡️ 9999965857 🚀 No Advance 24HRS...
VVVIP Call Girls In Greater Kailash ➡️ Delhi ➡️ 9999965857 🚀 No Advance 24HRS...
 
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Navi Mumbai Just Call 9907093804 Top Class Call Girl Service Avail...
 
It will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayIt will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 May
 
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...
KYC-Verified Accounts: Helping Companies Handle Challenging Regulatory Enviro...
 

Antimicrobial stewardship

  • 1.
  • 2. Introduction The antimicrobials are not a human invention.  They were present/produced by fungi, soil actinomycetes, and other microorganisms for the last few thousand of years.  To counteract the effects of these, genes encoding for resistance have also been present in nature for similar time period. 
  • 3. Introduction  Introduction of these genes in human/animal commensal flora or pathogenic organisms together with the introduction of antimicrobials for human use has led to the present day epidemic of antimicrobial resistance.
  • 5. Antimicrobial use and Resistance      A few million years ago, one species of finch migrated to the rocky Galapagos from the mainland of Central or South America. From this one migrant species would come many -at least 13 species of finch evolving from the single ancestor. This process in which one species gives rise to multiple species that exploit different niches is called adaptive radiation. On various islands, finch species have become adapted for different diets: seeds, insects, flowers, the blood of seabirds, and leaves. The ecological niches exert the selection pressures that push the populations in various directions.
  • 6. Antimicrobial use and Resistance Darwinian theories of evolution and survival of the fittest suggest that the selection and maintenance of MDR bacteria would not happen without antibiotic exposure and the heavier the exposure, the greater the resistance problem.  Emergence of VRE due to vancomycin use (?); carbapenem resistance in Acinetobacter and other GNB. 
  • 7. Antimicrobial use and Resistance Emergence of VRE due to usage of broad spectrum cephalosporins and clindamycin.  Fluoroquinolone with MRSA (quinolones are known to modulate phage induction and and horizontal gene transfer)  High-level fluoroquinolone resistance (mainly caused by gyrA mutations) has also been shown to be associated with CTX-M enzymes (co-carriage on conjugative plasmids). 
  • 8. Antimicrobial use and Resistance As bacteria are thought to have evolved 3500 million years ago, 60-70 years is but „a second in a day‟ in evolutionary time.  Despite this, we have seen the development, even since their early use, of antibiotic resistance in many bacterial species. 
  • 9. Antimicrobial use and Resistance  Antibiotic resistance genes were present at very low levels prior to the introduction of antibiotics and it is largely the selective pressure of antibiotic use and the resulting exposure of bacteria, not only in humans but also in animals and the environment, which has caused the rise.
  • 10. Causal associations between antimicrobial use and the emergence of antimicrobial resistance. Changes in antimicrobial use are paralleled by changes in the prevalence of resistance.  Antimicrobial resistance is more prevalent in health care–associated bacterial infections, compared with those from community-acquired infections. 
  • 11. Causal associations between antimicrobial use and the emergence of antimicrobial resistance Patients with health care–associated infections caused by resistant strains are more likely than control patients to have received prior antimicrobials.  Areas within hospitals that have the highest rates of antimicrobial resistance also have the highest rates of antimicrobial use.  Increasing duration of patient exposure to antimicrobials increases the likelihood of colonization with resistant organisms. 
  • 12. Antibiotic Use Antibiotic Use Causes Resistance Maintains Resistance Don’t forget antibiotic use to modulate resistance and control outbreaks eg. patient decontamination regimens By Patient-staff-patient Spreads Resistance Patient-patient ?Patient-environment / equipment – patient Cross Infection
  • 13. What is antimicrobial stewardship?  Stewardship – „careful and responsible management of something entrusted to one‟s care‟.  Antimicrobial stewardship refers to the „careful and responsible management of antimicrobials entrusted to the care of ……  Usually medical microbiologists, infectious diseases physicians, antimicrobial pharmacists, infection control nurses etc.
  • 14. Antimicrobial Stewardship  An antimicrobial stewardship program is an ongoing effort by a health care institution to optimize antimicrobial use among hospitalized patients in order to improve patient outcomes, ensure costeffective therapy, and reduce adverse sequelae of antimicrobial use (including antimicrobial resistance).(MacDougall and Polk 2005, Clin Microbiol Rev,18).
  • 15. Antimicrobial Stewardship  Antimicrobial stewardship entails diverse interventions aimed at reducing inappropriate antimicrobial use while optimizing antimicrobial drug selection, dosing, route and duration of therapy in order to maximize clinical cure or prevention of infection and to limit unintended consequences, such as the emergence of resistance, adverse drug events and the selection of pathogenic organisms. (Dellit TH et al 2007 Clin Infect Dis,44)
  • 16. Antimicrobial Stewardship The optimal selection, dosage, and duration of antimicrobial treatment that results in the best clinical outcome for the treatment or prevention of infection, with minimal toxicity to the patients and minimal impact on subsequent resistance.  4 D‟s of optimal antimicrobial therapy are: right Drug, right Dose, De-escalation to pathogen directed therapy, and right Duration of therapy. 
  • 17. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS Infectious Diseases Physicians:  Design, implementation, and function of the program.  Supervision by an infectious diseases physician is necessary to ensure that therapeutic guidelines, antimicrobial restriction policies, or other measures are based on the best evidence and practice and will not put patients at risk. 1.
  • 18. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS 2. Clinical and Hospital Pharmacists  Pharmacists often act as the effector arms for antimicrobial stewardship programs  They are well positioned for this effort because of their role in processing medication orders and their familiarity with the hospital formulary.
  • 19. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS However, the broad responsibilities of these pharmacists generally do not allow adequate time for a comprehensive review of antimicrobial therapy.  In addition, these pharmacists may not have adequate training in infectious diseases to feel comfortable providing recommendations for complex cases. 
  • 20. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS 3. Clinical Microbiologists  The clinical microbiology laboratory is a key component in the function of antimicrobial stewardship programs.  Summary data on antimicrobial resistance rates allow the antimicrobial stewardship team to determine the current burden of antimicrobial resistance in the hospital, facilitating decisions as to which antimicrobials to target for restriction or review.
  • 21. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS Preparation of antibiograms specific to certain patient care areas, especially intensive care units, may allow identification of local problems and focussed antimicrobial stewardship and infection control efforts  Dissemination of antibiograms to clinicians may allow better selection of empirical therapy based on local susceptibility patterns. 
  • 22. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS The microbiology laboratory can also encourage focused antimicrobial selection by cascade reporting of susceptibility results: depending on the organism‟s susceptibility, only certain (usually narrower-spectrum) antimicrobials are reported.  Hidden susceptibility results should be made available upon request in cases where toxicity, allergy, co-infections, or other considerations make first-line therapy suboptimal. 
  • 23. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS 4. Infection Control Staff and Hospital Epidemiologists  Infection control staff gather highly detailed data on nosocomial infections which may assist in the antimicrobial stewardship team‟s evaluation of the outcomes of their strategies.  In turn, antimicrobial stewardship programs may be able to assist in efforts to control outbreaks by focused monitoring and/or restriction of antimicrobials in the targeted units
  • 24. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS  Any antimicrobial stewardship program should either be fully integrated with or work closely with a hospital‟s infection control program; such collaboration has the opportunity to synergistically reduce antimicrobial resistance and improve patient outcomes.
  • 25. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS 5. Hospital Administrators  No antimicrobial stewardship program is likely to be successful without at least passive endorsement by hospital leadership.  Program funding, institutional policy, and physician autonomy are core issues in the development of antimicrobial stewardship programs that must be addressed by hospital administration.
  • 26. ROLES OF INDIVIDUALS IN ANTIMICROBIAL STEWARDSHIP PROGRAMS  Without adequate support from hospital leadership, program funding will be inadequate or inconsistent since the programs do not generate revenue.  If hospital leadership is not publicly committed to the program, recalcitrant prescribers may thwart attempts to improve antimicrobial use without fear of sanction.
  • 27. Methodological Issues Outcome Measurements  The change in antimicrobial usage is the most common outcome measured in studies of stewardship programs.  Common outcome variables include quantity of total antimicrobial use, quantity of targeted antimicrobial use, duration of therapy, percentage of oral versus intravenous drug administration, and antimicrobial drug expenditures. 1.
  • 28. Methodological Issues-1. Outcome measurements Common clinical outcomes include allcause mortality, infection-related mortality, duration of hospitalization, and rates of readmission.  Microbiologic outcomes include the percentage of organisms resistant to a certain antimicrobial, percentage of multidrug-resistant organisms, or number of infections due to specific organisms. 
  • 29. Methodological Issues 2. Study Design  Use of flawed methodologies may overestimate or underestimate the effect of interventions on outcomes.  In a review of 306 studies of interventions to improve antimicrobial prescribing in hospitals, 70% did not meet the minimum criteria of the Cochrane Collaboration‟s Effective Practice and Organization of Care Group. (Ramsey et al 2003, J Antimicrob Chemother; 52).
  • 30. Methodological Issues-2. Study Design    The most commonly excluded studies were those using uncontrolled before-and-after designs (46%) or inadequate interrupted time series analysis (24%). Analysis need to be done using interrupted time series with segmented regression , a method of analysis applied to before-and-after quasiexperimental study designs. This methodology requires measurements at multiple time points both before and after the intervention, allowing evaluation of both the immediate change due to the intervention (change in level) and the sustained changes (change in slope).
  • 31. Segmented regression analysis of interrupted time series data.
  • 32. Methodological Issues 3. Effect of Multiple Interventions  Analysis of the efficacy of interventions to improve antimicrobial use is complicated by the simultaneous employment of multiple different strategies by antimicrobial stewardship programs.  It becomes difficult to compare the effect of different strategies and conclude which is most effective.
  • 33. Methodological Issues 4. Publication Bias  There is a perception that positive results are more noteworthy and manuscripts are more likely to be submitted and accepted for publication if the report demonstrates positive results  Thus, it is unclear whether antimicrobial stewardship programs are generally effective in controlling antimicrobial use (and sometimes in improving resistance and clinical outcomes), or whether the published literature only reflects the experience of successful programs.  The careful study and publication of the results of implementations of antimicrobial stewardship strategies, successful or unsuccessful, should be encouraged.
  • 34. Antibiotic Stewardship Programmes/Strategies   1. 2. 3. 4. 5. Antimicrobial stewardship programs may be generally classified according to the strategy by which they seek to affect antimicrobial use. However many programs use a combination of such strategies. Education and Guideline Implementation Strategies Formulary and Restriction Strategies Review and Feedback Strategies Computer-Assisted Strategies Antibiotic Cycling Strategies.
  • 35. 1. Education and Guideline Implementation Strategies      A key foundation in encouraging appropriate antimicrobial use in hospitals is defining what an institution considers appropriate antimicrobial use. Because of limited time to teach antimicrobial pharmacology and infectious diseases in the medical school curriculum, physicians often acquire their antimicrobial prescribing habits from the practice of their colleagues, the recommendations of antibiotic handbooks, and from information provided by representatives of the pharmaceutical industry
  • 36. 1. Education and Guideline Implementation Strategies Information from these sources may vary widely and conflict with what is considered best practice at an institution.  Although the vast majority of physicians recognize antimicrobial resistance as an important problem, most underestimate the true degree of antimicrobial resistance in their own institutions 
  • 37. 1. Education and Guideline Implementation Strategies Physicians are primarily concerned with the effects of antimicrobials in the individual patients whose care they have been charged with.  In a hypothetical case scenario, the risk of contributing to antimicrobial resistance was rated lowest among seven factors influencing a physician‟s choice of antimicrobial agent. 
  • 38. 1. Education and Guideline Implementation Strategies To counter these perceived conflicts in knowledge and practice, institutions may attempt to provide guidelines for antimicrobial use and educate clinicians regarding preferred antimicrobial therapy.  This strategy attempts to influence providers‟ prescribing during their evaluation of the patient and selection of antimicrobial therapy 
  • 39. 1. Education and Guideline Implementation Strategies Academic detailing refers to one-on-one educational sessions between an academic clinician educator (usually a physician or pharmacist) and the clinician targeted for education .  Also referred to as reverse detailing or counterdetailing, this method co-opts the strategy of individualized attention used by pharmaceutical industry representatives (detailers). 
  • 40. 1. Education and Guideline Implementation Strategies Prescriber feedback consists of providing data to clinicians regarding their prescribing habits, with comparisons to expected norms (e.g.guidelines) or to other prescribers in the same practice area.  In the hospital setting, passive interventions involve measures such as providing posters, handouts, or printed guidebooks, or minimally interactive educational sessions such as Grand Rounds. 
  • 41. 1. Education and Guideline Implementation Strategies Reviews of studies of provider behaviour change suggest that active, personalized interventions such as academic detailing are more effective than passive dissemination of information at eliciting desired changes.  Education- and guideline-based strategies should be considered primarily as a starting point for antimicrobial stewardship programs. 
  • 42. 2. Formulary and Restriction Strategies Because of resistance to compliance with guidelines for antimicrobial usage, external control over clinicians‟ prescribing of these drugs may be implemented.  This commonly takes the form of establishment of an antimicrobial formulary, such that only selected antimicrobial agents are freely dispensed by the pharmacy. 
  • 43. 2. Formulary and Restriction Strategies   Other agents may only be available if certain criteria for use are met (criterion-monitored strategies), if approval for use is obtained from a specialist in infectious diseases (prior-authorization strategies), or may not be available at all (closed-formulary strategies). The goal of restriction-based policies may be a reduction in drug costs to the hospital (through restriction of more-expensive agents), a reduction in the growth of antimicrobial resistance (through restriction of agents considered to be more likely to contribute to resistance), or both.
  • 44. 2. Formulary and Restriction Strategies Restriction programs may also be based on the potential of antimicrobials to select for certain resistant organisms.  “Squeezing the balloon” phenomenon; changing from the use of one agent to another may reduce resistance to the first drug, but increase resistance to the second drug. 
  • 45. 2. Formulary and Restriction Strategies   In response to an outbreak of an extended-spectrum beta-lactamase-producing Klebsiella sp., a hospital instituted strict restrictions on all cephalosporin use . Subsequently, the incidence of resistant Klebsiella infection decreased significantly. However, due to an increase in use of imipenem/cilastatin, the incidence of imipenem-resistant Pseudomonas aeruginosa increased. Heavy use of piperacillin-tazobactam was associated with high rates of piperacillin-resistant Pseudomonas infections in a medical-surgical intensive care unit . Substitution of Pip-Taz with imipenem led to a decrease in resistance piperacillin resistance in Pseudomonas infections, but an increase in imipenem resistance.
  • 46. 3. Review and Feedback Strategies Restriction strategies may be effective at channelling use of antimicrobials towards preferable agents, but there are limitations to the approach.  There may be inadequate personnel or institutional commitment for a restrictive approach.  Restriction strategies do not consider the appropriateness of use of non-restricted antimicrobials, which make up the vast majority of antimicrobials used in the hospital. 
  • 47. 3. Review and Feedback Strategies   To optimize the use of non-restricted antimicrobials, or to manage the use of targeted antimicrobials in institutions where restriction strategies are not in place, programs built around antimicrobial review and feedback may be instituted. Such a program involves the retrospective (hours to days) review of antimicrobial orders If an order appears to be inappropriate, a member of the antimicrobial management team contacts the prescriber in an effort to optimize therapy.
  • 48. 3. Review and Feedback Strategies    Review and feedback strategies may be especially important in streamlining antimicrobial use. This realization has led to the advocacy of early, broad-spectrum empirical antimicrobial therapy for a number of hospital infections. For example, recent American Thoracic Society/Infectious Diseases Society of America guidelines for hospital-acquired pneumonia recommend three-drug combination therapy (an antipseudomonal beta-lactam, an aminoglycoside or fluoroquinolone, and vancomycin or linezolid) for empirical therapy in patients with late-onset pneumonia.
  • 49. 3. Review and Feedback Strategies This approach reduces the risk of a patient‟s receiving inadequate therapy;  However, administration of multiple broadspectrum agents may increase the risk of development of resistance in the patient‟s (and the hospital‟s) bacterial flora.  Thus, it is crucial for clinicians to change to the narrowest spectrum appropriate agent to treat the infecting pathogen once it is isolated and discontinue antimicrobials if infection is unlikely. 
  • 50. 3. Review and Feedback Strategies  Although adherence to these two principles should be a fundamental tenet of medical practice, in reality a formal process (such as a guideline or critical pathway) or the contribution of the antimicrobial stewardship team reviewing such orders may be required.
  • 51. 4. Computer-Assisted Strategies The increasing computerization of the hospital environment offers new opportunities for programmes to optimize antimicrobial use.  These opportunities have primarily been associated with implementation of computerized physician order-entry systems in hospitals.  The order-entry encounter can be designed to facilitate each of the antimicrobial stewardship strategies . 
  • 52. 4. Computer-Assisted Strategies    Educational strategies may be as simple as a link to the institution‟s guidelines for therapy, or as sophisticated as computerized expert systems that integrate patient-specific laboratory and microbiology data in devising a suggested therapeutic regimen. If a prescriber enters an order for a restricted agent, a list of formulary alternatives can be suggested, along with the pager number needed to obtain authorization. When an agent targeted for review is ordered, the data can be forwarded in real time or entered into a queue for later review by antimicrobial stewardship personnel.
  • 53. 4. Computer-Assisted Strategies    The most advanced programs integrate patient-specific data extracted from hospital information systems to provide tailored recommendations for therapy using rulesbased criteria (expert systems). The choice of antimicrobial is guided by the results of the patient‟s cultures (for definitive therapy) or by hospital-specific resistance patterns (for empirical therapy). Many softwares are commercially available which can be integrated in hospital information system.
  • 54. 5. Antibiotic Cycling Strategies In the 1980s, studies examining formulary substitution of aminoglycosides (amikacin for gentamicin and tobramycin) suggested a strategy of rotating antimicrobials might be effective in slowing the emergence of resistance to any one agent.  These studies have led to the development of strategies utilizing the scheduled rotation of antimicrobials in order to minimize the emergence of bacterial resistance. 
  • 55. 5. Antibiotic Cycling Strategies    These programs typically target Gram-negative resistance (the cycled antimicrobials are those primarily active against Gram-negative organisms) and are generally limited to the intensive care unit setting. Theoretically, during the periods when an antimicrobial is out of rotation and its use is minimal, resistance to that drug will decline. The idea is to reduce selective pressure to any one antimicrobial class by providing heterogeneity in drug use –in the case of cycling, temporal heterogeneity (by time period) rather than spatial (by patient) heterogeneity.
  • 56. 5. Antibiotic Cycling Strategies  However, compliance with the cycling protocol may be low, for a number of reasons: physicians may ignore the protocol and prescribe off-cycle antimicrobials to their patients, allergies or toxicity may preclude administration of the on-cycle drug, and the final regimen may be tailored to culture results.
  • 57. Conclusions Although resistance is a worldwide concern, it is first and foremost a local problem: selection for and amplification of resistant members of a species are occurring in individual hospitals (and communities), which can then spread worldwide.  Commitment to implementation of antimicrobial stewardship programs must come from the highest levels of hospital administration. 
  • 58. Conclusions Once a commitment to establishing an antimicrobial stewardship program is made, program personnel/committee need to be put into place.  The committee then needs to decide what strategies their program will use to improve antimicrobial use. 
  • 59. T